Abeona Therapeutics is at a critical juncture, trading near 52-week lows ahead of its first ZEVASKYN revenue update in Q3.

Get Q3 2025 earnings insights on Seer, Inc. (SEER): revenue growth, instrument momentum, partnership updates & risks.

Q3 2025 Earnings Call Transcript November 5, 2025 Operator: Good day, and thank you for standing by. Welcome to the Flywire ...

Q3 2025 Earnings Call Transcript November 6, 2025 Tripadvisor, Inc. misses on earnings expectations. Reported EPS is $0.4274 ...

Discover how DAOs revolutionize drug discovery through decentralized funding, transparency, and community governance.

Deploy sliding time windows that continuously analyze supply chain and operations data streams. A 30-minute window can ...

Cascale expands its Higg Index tools into furniture, uniting data and design to drive verified sustainability, transparency, ...

And this is if I can complement the we see that the trajectory is robust our big international clients, in particular the bio ...

In other words, we can use AI as a simulated audience: a stand-in that reacts to a data story as if it were a specific type ...

Among the most significant challenges facing the healthcare industry are rising costs, the aging population and the shrinking healthcare workforce. On top of that, policy changes are putting pressure ...

With the deepening of digital transformation, IT enterprises are not only the core practitioners of technological innovation but also the active implementers of their own digital transformation. As ...